Conditions: Anemia Chronic Kidney Disease
Keywords: CKD Anemia correction darbepoetin alfa
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 358
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine whether once monthly (QM) dosing of darbepoetin alfa is non-inferior to that of once every 2 week (Q2W) dosing of darbepoetin alfa for the correction of anemia in patients with Chronic Kidney Disease who are not receiving dialysis.

Detailed description:

Arms:
arm 1: Q2W administration of darbepoetin alfa. arm 2: QM administration of darbepoetin alfa

Interventions: intervention 1: darbepoetin alfa
Intervention descriptions: intervention 1: Drug administered either Q2W or QM using a prefilled syringe. Allowable doses of: 10, 20, 30, 40, 50, 60, 80, 100, 130, 150, 200, 300, 400 or 600 mcg.

Protocol document: